Three COVID-19 vaccines at clinical trial stage in India: ICMR
First Published: 15th September, 2020 20:54 IST
Three COVID-19 vaccines are at a clinical trial stage in the country and two indigenous vaccine candidates have completed phase one trial, Indian Council of Medical Research (ICMR) DG Dr
Three COVID-19 vaccines are at a clinical trial stage in the country and two indigenous vaccine candidates have completed phase one trial, Indian Council of Medical Research (ICMR) DG Dr Balram Bhargava said on Tuesday.
“Three vaccines are at the clinical trial stage in India. Zydus Cadila and Bharat Biotech have completed phase-I trials. Results are being analysed. They have started recruitment for the second phase,” Dr Bhargava said at a press conference here.
He was replying to a question on the status of COVID-19 vaccines in the country.
“Serum Institute of India (SII) has completed phase II-B3 trials. They took seven days break and will start phase-III trial (with 1,500 patients at 14 locations) after clearances,” he added.
The Drugs Controller General of India (DCGI) had asked SII to suspend any new recruitment in phase 2 and 3 clinical trials for the COVID-19 vaccine till further orders after reports from AstraZeneca that it had paused the ongoing trial of nCoV19 coronavirus vaccine (recombinant) as a volunteer developed an unexplained illness.
AstraZeneca, which has partnered with Oxford University for development of the vaccine, has since resumed trials in UK.
There is yet no specific drug and vaccine available yet for coronavirus. Dr Bhargava had said that four factors would need to be considered once India has a safe and effective vaccine against coronavirus – priority and fair distribution of the vaccine, logistics and roll out in a cold chain, stockpiling and training of people who are to be given this vaccine.
He said India has been rolling out other vaccines for many years and has the requisite know-how.
Experts say a sustained behavioural change is required at least till there is a safe and effective vaccine. This includes wearing a mask, proper hand hygiene and physical distancing.
India’s COVID-19 case count crossed the 49-lakh mark on Tuesday. A total of 49,30,237 cases have been reported in the country including 9,90,061 active cases, 38,59,400 cured/discharged/migrated patients and 80,776 deaths. (ANI)
COMMENTS
TOPMOST STORY NOW
Live Meghalaya petrol bomb attacks: Asked DGP to ensure such incidents do not repeat, says Dy CM Prestone Tynsong
01st May 2024Live Petrol bombs the new weapon of violence in Meghalaya?
01st May 2024Live PMEAC Member Sanjeev Sanyal delivers Prof Sarat Mahanta Memorial Lecture in Guwahati
01st May 2024Live Babar Azam moves to fourth spot in T20I rankings, Suryakumar Yadav continues to be at top
01st May 2024WE RECOMMEND
Close to 100 schools in Delhi-NCR get bomb threat mails. Who sent the mails? What is the truth?
According to Delhi Police, the bomb threats sent via email to schools originated from Russia, as indicated by the IP address of the email, which was traced back to the domain "mail.ru"
01st May 2024Multiple schools across Delhi-NCR receive bomb threat, students evacuated; Delhi Police begin probe
Bomb detection teams, bomb disposal squads and officials of Delhi Fire Service have been rushed to schools and search operations are underway, a police officer said.
01st May 2024Delhi HC directs government to frame policy for compensating deaths due to Chinese ‘manjha’
In 2017, the Chinese Manjha was banned by the Indian government.
01st May 2024Licence of 14 Patanjali products cancelled. Check details here
In an affidavit filed in the Supreme Court, the licencing body said that it had suspended licenses of 14 products manufactured by Patanjali's Divya Pharmacy in connection with the misleading advertisements case.
30th April 2024Delhi Police summons Telangana CM Revanth Reddy in Amit Shah fake video case
The Congress leader has been asked to appear before Delhi Police's IFSO unit (Cyber Unit) on May 1 with his mobile phone.
29th April 2024